Literature DB >> 12082656

Advances in quality of life measurements in oncology patients.

David Cella1, Chih-Hung Chang, Jin-Shei Lai, Kimberly Webster.   

Abstract

Accurate assessment of the quality of life (QOL) of patients can provide important clinical information to physicians, especially in the area of oncology. Changes in QOL are important indicators of the impact of a new cytotoxic therapy, can affect a patient's willingness to continue treatment, and may aid in defining response in the absence of quantifiable endpoints such as tumor regression. Because QOL is becoming an increasingly important aspect in the management of patients with malignant disease, it is vital that the instruments used to measure QOL are reliable and accurate. Assessment of QOL involves a multidimensional approach that includes physical, functional, social, and emotional well-being, and the most comprehensive instruments measure at least three of these domains. Instruments to measure QOL can be generic (eg, the Nottingham Health Profile), targeted toward specific illnesses (eg, Functional Assessment of Cancer Therapy - Lung), or be a combination of generic and targeted. Two of the most widely used examples of the combination, or hybrid, instruments are the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Items and the Functional Assessment of Chronic Illness Therapy. A consequence of the increasing international collaboration in clinical trials has been the growing necessity for instruments that are valid across languages and cultures. To assure the continuing reliability and validity of QOL instruments in this regard, item response theory can be applied. Techniques such as item response theory may be used in the future to construct QOL item banks containing large sets of validated questions that represent various levels of QOL domains. As QOL becomes increasingly important in understanding and approaching the overall management of cancer patients, the tools available to clinicians and researchers to assess QOL will continue to evolve. While the instruments currently available provide reliable and valid measurement, further improvements in precision and application are anticipated. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12082656     DOI: 10.1053/sonc.2002.33535

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  13 in total

Review 1.  Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice?

Authors:  Davide Tassinari; Marco Maltoni; Sergio Sartori; Manuela Fantini; Barbara Poggi; Alberto Ravaioli
Journal:  Support Care Cancer       Date:  2004-12-03       Impact factor: 3.603

2.  Social networks and quality of life for long-term survivors of leukemia and lymphoma.

Authors:  Jung-Won Lim; Brad Zebrack
Journal:  Support Care Cancer       Date:  2005-07-09       Impact factor: 3.603

Review 3.  Quality of life research in neuro-oncology: a quantitative comparison.

Authors:  Elizabeth Klein; David Altshuler; Abhirami Hallock; Nicholas Szerlip
Journal:  J Neurooncol       Date:  2013-11-05       Impact factor: 4.130

Review 4.  Chemotherapy-induced peripheral neurotoxicity.

Authors:  Guido Cavaletti; Paola Marmiroli
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

5.  The relationship of quality of life and distress in prostate cancer patients compared to the general population.

Authors:  Markus Zenger; Antje Lehmann-Laue; Jens-Uwe Stolzenburg; Thilo Schwalenberg; Alexander Ried; Andreas Hinz
Journal:  Psychosoc Med       Date:  2010-06-30

6.  Quality of life estimate in stomach, colon, and rectal cancer patients in a hospital in China.

Authors:  Muhong Deng; Yanhong Lan; Shali Luo
Journal:  Tumour Biol       Date:  2013-05-17

Review 7.  Quality of life in adults with brain tumors: current knowledge and future directions.

Authors:  Raymond Liu; Margaretta Page; Karla Solheim; Sherry Fox; Susan M Chang
Journal:  Neuro Oncol       Date:  2008-11-10       Impact factor: 12.300

8.  Comparing health-related quality of life of cancer patients under chemotherapy and of their caregivers.

Authors:  Ioannis Vrettos; Konstantinos Kamposioras; Nick Kontodimopoulos; Evelina Pappa; Elissavet Georgiadou; Dionysios Haritos; Angelos A Papadopoulos; Dimitris Niakas
Journal:  ScientificWorldJournal       Date:  2012-04-24

9.  Experiencing neutropenia: quality of life interviews with adult cancer patients.

Authors:  Barry V Fortner; Kurt W Tauer; Ted Okon; Arthur C Houts; Lee S Schwartzberg
Journal:  BMC Nurs       Date:  2005-07-08

10.  Surrogate end points of quality of life assessment: have we really found what we are looking for?

Authors:  Davide Tassinari
Journal:  Health Qual Life Outcomes       Date:  2003-11-24       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.